Omnicare

Supreme Court to hear case sparked by Omnicare deals

Supreme Court to hear case sparked by Omnicare deals

By

A recent $4 million legal settlement over kickbacks for anemia drug Aranesp is small change compared to other recent deals Omnicare has made with federal authorities. News of these payouts hasn't escaped long-term care pharmacy investors, some of whom filed their own charges against the pharmacy provider, launching a case that is now set to be heard by the U.S. Supreme Court.

Supreme Court to decide whether Omnicare made illegal false statements to investors about nursing home kickbacks

By

The U.S. Supreme Court will hear a case alleging that the nation's largest long-term care pharmacy, Omnicare, broke the law by keeping potential investors in the dark about kickbacks to nursing homes, the high court announced Monday.

Omnicare reaches $4 million settlement over charges of receiving kickbacks for putting SNF residents on Aranesp

By

Omnicare, the nation's largest long-term care pharmacy, has reached a $4 million settlement agreement over allegations that the company conspired with a pharmaceutical company to switch nursing home residents to the anemia drug Aranesp, the U.S. Department of Justice announced Friday.

Court expresses concern over Omnicare drug packaging practices but dismisses False Claims suit

By

A whistleblower exposed disturbing drug packaging practices being used by long-term care pharmacy Omnicare Inc., but the charges don't fall under the False Claims Act, a federal appeals court recently ruled.

J&J settles antipsychotics cases in historic $2.2B deal

J&J settles antipsychotics cases in historic $2.2B deal

By

Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes. The agreement also will settle kickback charges related to the nation's largest long-term care pharmacy, Omnicare.

A tough retirement nest egg, the whistle-blowing way

A tough retirement nest egg, the whistle-blowing way

By

Two big reactions hit me when news of Johnson & Johnson's $2.2 billion Risperdal settlement with the government landed this week. First, J&J probably made a lot more than it's paying out and, second, some individual probably is going to cash a nice paycheck for bringing it all to light.

Johnson & Johnson to pay $2 billion in settlement over antipsychotic drugs in nursing homes

Johnson & Johnson to pay $2 billion in settlement over antipsychotic drugs in nursing homes

By

Pharmaceuticals giant Johnson & Johnson and some subsidiaries will pay more than $2.2 billion to settle claims that they inappropriately promoted antipsychotic drugs for use in nursing homes, the U.S. Department of Justice announced Monday. The agreement is one the largest ever of its kind, and will also settle charges that the companies paid kickbacks to the nation's largest long-term care pharmacy, Omnicare.

Omnicare reaches $120 million settlement in whistleblower suit over SNF drug prices

Omnicare reaches $120 million settlement in whistleblower suit over SNF drug prices

By

Omnicare, the nation's largest provider of long-term care pharmacy services, has agreed to pay $120 million to settle a False Claims Act lawsuit over Medicare Part A drug pricing, the company announced Wednesday. The settlement likely is one of the largest in a whistleblower case in which the government did not intervene, according to Frederick Morgan, one of Gale's attorneys at the firm Morgan Verkamp LLC.

Omnicare will benefit from the Affordable Care Act, GOP opposition is 'perplexing,' CEO says

By

Omnicare, the nation's largest long-term care pharmaceutical services provider, is positioned to be successful as insurance coverage expands under the Affordable Care Act, according to CEO John Workman.

Nursing home operators settle Omnicare kickback case for $5 million

By

Two former nursing home executives have agreed to pay $5 million to settle a whistleblower lawsuit involving long-term care pharmacy giant Omnicare Inc., according to the Chicago Tribune.

Kindred shifts allegiance to Omnicare from PharMerica

Kindred shifts allegiance to Omnicare from PharMerica

By

Kindred Healthcare will split with PharMerica and instead partner with Omnicare in 2014, marking a significant change in the landscape of long-term care pharmacy services providers.

Judge allows whistleblower FCA case against Omnicare

Judge allows whistleblower FCA case against Omnicare

By

A whistleblower who alleges Omnicare Inc. paid kickbacks to nursing homes did not violate the False Claims Act, a judge has ruled.

Nursing home operators to face trial over kickback scheme

By

Two nursing home operators are set to stand trial to face whistleblower allegations that Omnicare Inc. paid them kickbacks during its purchase of Total Pharmacy.

Omnicare settles federal whistleblower suit

By

An Illinois federal judge approved the dismissal of a whistleblower lawsuit against Omnicare, following a settlement agreement on July 9, according to local media reports.

Kindred breaks with PharMerica, plans to partner with Omnicare

By

Kindred Healthcare will split with pharmacy partner PharMerica and join forces with Omnicare at the end of 2013, according to documents filed with the Securities and Exchange Commission.

Kindred teams with Omnicare, splits with skilled nursing pharmacy PharMerica

Kindred teams with Omnicare, splits with skilled nursing pharmacy PharMerica

By

Major long-term care provider Kindred Healthcare will split with its current pharmacy partner, PharMerica, and team with the sector's largest pharmacy, Omnicare, at the end of 2013, according to documents filed with the Securities and Exchange Commission.

Judge denies Omnicare's 'untimely' motion to disqualify whistleblower in nursing home kickbacks case

By

Omnicare has failed to disqualify a whistleblower who alleges the long-term care pharmacy paid kickbacks to nursing homes, ruled a district court judge.

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

Judge dismisses claims of 'nationwide' Medicare fraud in Omnicare antipsychotics case

By

Long-term care pharmacy Omnicare will not face charges that it engaged in "nationwide" Medicare fraud for off-label antipsychotics prescriptions, a federal judge recently ruled. However, the pharmacy still faces more limited False Claims Act charges over billing for antipsychotic drugs allegedly used for dementia care.

Amgen pays $25 million to settle whistleblower case over kickbacks to long-term care pharmacies

By

Biotechnology company Amgen will pay $24.9 million in a settlement over whistleblower allegations that the company paid kickbacks to long-term care pharmacies to increase the use of an anemia drug in nursing homes.

MDI Achieve announces pharmacy integration

MDI Achieve announces pharmacy integration

MDI Achieve announced that MatrixCare is now integrated with several leading pharmacy service firms. These include Omnicare, PharMerica, and FrameworkLTC.

Walgreens back in the long-term care market, sort of

With more vendors targeting the hospice market, two drug giants appear ready to face off. Walgreens left the institutional-pharmacy business in 2010, of which hospice pharmacy is a part, in a deal with Omnicare. Walgreens traded the unit for Omnicare's home-infusion business. Since then, Omnicare has been the market leader for hospice drugs. So why the strategy change for Walgreens?

New pharmacy player has big plans

The parent company of Golden Living officially launched AlixaRx with predictions it could become a $250 million per year business within 18 months.

Plans for massive long-term care pharmacy provider unveiled; AlixaRx launches

By

Executives tied to one of the nation's largest nursing home chains say a new institutional pharmacy model they unveiled this week could soon become the market's No. 3 player. The parent group of Golden Living officially launched AlixaRx this week with predictions it could become a $250 million per year business within 18 months.

David fights on after long-term care Goliath decides to bow out

David fights on after long-term care Goliath decides to bow out

By

The headlines were big. Really big. And they involved a long-term care corporate giant settling yet another lawsuit. But they didn't tell the story I really wanted to know about. And that you probably want to know about, too.

Omnicare to settle whistle-blower suit

By

Omnicare agreed to settle over claims it provided a kickback when it bought Total Pharmacy services LLC in 2004. Terms of the deal were not released.

Omnicare will pay $50 million over controlled substances charges

Omnicare will pay $50 million over controlled substances charges

Long-term care pharmacy provider Omnicare has agreed to pay the government $50 million to settle charges that it illegally dispensed controlled medications to long-term care residents.

Omnicare drops bid for PharMerica

Omnicare has officially ended its attempt to absorb PharMerica Corp. The reversal comes less than a month after federal regulators attempted to block the deal. Officials said the merger would have created an institutional pharmacy company that reaches nearly 60% of the nation's nursing home beds. PharMerica has repeatedly tried to prevent the takeover since it was announced last year. PharMerica countered that the offer was insufficient and was unlikely to survive antitrust scrutiny.

Omnicare ends PharMerica takeover attempt, posts 4Q profit

Leading long-term care pharmacy provider Omnicare, which announced this week that it has ended its efforts to takeover competitor PharMerica, posted a profit in the fourth quarter.

Omnicare extends purchase offer for PharMerica until January

Omnicare announced Monday that it is extending its offer to purchase all outstanding shares of rival PharMerica for $15 per share to Jan. 20. The original offer was scheduled to expire Dec. 2.

Mariner settles multimillion kickback case

Maryland and North Carolina are among several states set to receive a portion of the settlement stemming from a nursing home company kickback case.

Don't miss any McKnight's news

Featured Articles